BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6701 related articles for article (PubMed ID: 2511360)

  • 1. [Definitive diagnosis of early malignant melanoma lesions by the quantitative analysis of 5-S-cysteinyldopa in the tissue and touch fluorescence method].
    Kanematsu S; Morishima T
    Nihon Hifuka Gakkai Zasshi; 1989 Jun; 99(7):783-91. PubMed ID: 2511360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New regulators of melanogenesis are associated with purified tyrosinase isozymes.
    Hearing VJ; Korner AM; Pawelek JM
    J Invest Dermatol; 1982 Jul; 79(1):16-8. PubMed ID: 6806397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inheritance of cutaneous malignant melanoma (CMM) and dysplastic nevus syndrome (DNS).
    Pascoe L
    Am J Hum Genet; 1987 May; 40(5):464-5. PubMed ID: 3578283
    [No Abstract]   [Full Text] [Related]  

  • 4. Seven years experience with hyperthermic perfusions in extracorporeal circulation for melanoma of the extremities.
    Santinami M; Belli F; Cascinelli N; Rovini D; Vaglini M
    J Surg Oncol; 1989 Nov; 42(3):201-8. PubMed ID: 2811386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of pigmentation in melanoma cells by trimethylpsoralen in the absence of ultraviolet irradiation.
    Borkovic SP; Alper JC; McDonald CJ
    Br J Dermatol; 1983 May; 108(5):525-32. PubMed ID: 6849821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface distribution of wheat germ agglutinin binding sites of human melanoma cell lines with low and high tumorigenicity.
    Berthier-Vergnes O; Deugnier MA; Reano A; Doré JF
    Biochem Int; 1985 Nov; 11(5):669-76. PubMed ID: 4091844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternatives to enucleation in the management of choroidal melanoma.
    Foulds WS; Damato BE
    Aust N Z J Ophthalmol; 1986 Feb; 14(1):19-27. PubMed ID: 3964476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echographic and histologic tumor height measurements in uveal melanoma.
    Nicholson DH; Frazier-Byrne S; Chiu MT; Schiffman J; Hughes JR; Novinski EK
    Am J Ophthalmol; 1985 Sep; 100(3):454-7. PubMed ID: 3898853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative evaluation of anticancer agents against human melanoma cells implanted in nude mice.
    Lockshin A; Giovanella BC; Stehlin JS
    Exp Cell Biol; 1986; 54(3):149-54. PubMed ID: 3743866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of new semisynthetic saframycin derivatives.
    Kaneda S; Hour-Young C; Yazawa K; Takahashi K; Mikami Y; Arai T
    Jpn J Cancer Res; 1986 Oct; 77(10):1043-9. PubMed ID: 3096920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient.
    Doucet C; Meazza R; Pottin-Clemenceau C; Scudeletti M; Brouty-Boye D; Ferrini S; Alileche A; Taoufik Y; Jasmin C; Azzarone B; Indiveri F
    Melanoma Res; 1997 Aug; 7 Suppl 2():S7-17. PubMed ID: 9578412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial results with one-year minimum follow-up of the first 146 patients with a uveal melanoma treated with protons at CPO (Orsay).
    Schlienger P; Habrand JL; Schwartz L; Desjardins L; d'Hermies F; Frau E; Mazal A; Delacroix S; Nauraye C; Ferrand R; Louis M
    Bull Cancer Radiother; 1996; 83 Suppl():212s-4s. PubMed ID: 8949782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Adriamycin on liposomal muramyl tripeptide's ability to up-regulate monocyte cytokine expression.
    Asano T; Fujimaki W; McWatters A; An T; Matsushima K; Kleinerman ES
    Cancer Immunol Immunother; 1993 Nov; 37(6):408-11. PubMed ID: 8242665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleural mesothelioma presenting as an axillary lymph node metastasis with anemone cell appearance.
    Lloreta J; Serrano S
    Ultrastruct Pathol; 1994; 18(1-2):293-8. PubMed ID: 8191642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative, phenotypic and functional and molecular characteristics of tumour-infiltrating lymphocytes obtained from unselected patients with malignant melanomas and expanded in vitro in the presence of recombinant interleukin-2.
    Melioli G; Guastella M; Semino C; Meta M; Pietra G; Ponte M; Queirolo P; Sertoli MR; Martini L; Reali UM
    Melanoma Res; 1994 Apr; 4(2):127-33. PubMed ID: 8069098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocytes infiltrating primary cutaneous neoplasms selectively express the cutaneous lymphocyte-associated antigen (CLA).
    Gelb AB; Smoller BR; Warnke RA; Picker LJ
    Am J Pathol; 1993 May; 142(5):1556-64. PubMed ID: 7684198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micronucleus formation in human melanoma xenografts following exposure to hyperthermia.
    Rofstad EK; Falkvoll KH; Oftedal P
    Radiat Environ Biophys; 1984; 23(1):51-60. PubMed ID: 6709827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PALA, vindesine, and cisplatin combination chemotherapy in advanced malignant melanoma. A pilot study.
    Voigt H; Kleeberg UR
    Cancer; 1984 May; 53(10):2058-62. PubMed ID: 6231091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting anaerobic glycolysis in mouse and rat liver and in Morris rat hepatomas.
    Woods M; Burk D; Hunter J
    J Natl Cancer Inst; 1968 Aug; 41(2):267-86. PubMed ID: 4386137
    [No Abstract]   [Full Text] [Related]  

  • 20. [Increase in the effectiveness of the radiation therapy of tumors with actinomycins].
    Gotlib VIa; Nivinskaia MM; Pelevina II
    Med Radiol (Mosk); 1979 Apr; 24(4):24-9. PubMed ID: 374918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 336.